Just Earth News | @justearthnews | 24 Nov 2020, 03:32 am Print
Sputnik V Moscow/Sputnik: Over 117,000 doses of Russia's coronavirus vaccine Sputnik V have been already released into the market, and there are plans to produce over 2 million doses by the end of the year, Deputy Prime Minister Tatyana Golikova said on Tuesday.
In August, Sputnik V, developed by the Gamaleya research institute, became the world's first registered vaccine against COVID-19. It is now in phase III post-registration clinical trials.
"Since the moment of Sputnik V state registration, over 117,000 doses of the vaccine have been released into civil circulation. Producers plan to produce over 2 million doses by the year end. Currently, immunization of high-risk groups, doctors and teachers is prioritized," Golikova told the coordination council of human rights commissioners.
- Pakistan: Health department begins probing two death as deague cases rise
- WHO report shows one in six bacterial infections globally are resistant to standard antibiotics. Why is the situation alarming?
- Maldives becomes world's first nation to eliminate mother-to-child transmission of hepatitis B
- WHO report: 1 in 10 healthcare workers in Europe battling suicidal thoughts
- Mary Brunkow, Fred Ramsdell and Shimon Sakaguchi win Nobel Prize in Medicine. What did they discover?
